Advancements in CRISPR Technology Pave the Way for Clinical Trials and Precise Gene Targeting

Researchers are developing a new wave of CRISPR-based gene editing techniques that offer more precision and versatility than the original CRISPR-Cas9 system. These next-generation systems, such as base editing and prime editing, can change individual DNA bases, insert or delete small stretches of DNA, and alter the epigenome to regulate gene activity. Base editing therapies are already in early clinical trials, while prime editing is being enhanced for efficiency. The regulatory approval of classical CRISPR-Cas9 therapies paves the way for these advanced techniques, expanding the possibilities for treating genetic disorders and diseases.